Neogen and Biomatter Partner to Advance Enzyme-Based Food Safety Solutions
ByAinvest
Tuesday, Aug 12, 2025 2:48 am ET1min read
LLY--
Neogen, with a market capitalization of $1.1 billion and currently trading at $5.08, is a leading provider of food safety, livestock, and pet health solutions. The company operates in over 140 countries and generated annual revenue of $894.66 million in 2024. Biomatter, a next-generation enzyme design company, specializes in creating high-performance enzymes using its generative AI-powered Intelligent Architecture platform. The partnership aims to set new standards in the industry by making food and animal safety processes more efficient and cost-effective [1][2][3].
The collaboration combines Neogen's expertise in analytical development and technology with Biomatter's cutting-edge enzyme engineering capabilities. According to Dr. Jason Lilly, Neogen's Chief Scientific Officer, the partnership will unlock new possibilities that can enhance detection, improve efficiency, and ultimately protect and enhance the quality and safety of the global food supply [1][2][3].
Laurynas Karpus, Biomatter's Chief Executive Officer, stated that the collaboration aims to set new industry standards in food and animal safety. He emphasized that the partnership will make every step of the process more efficient, cost-effective, and ultimately more beneficial for the end user [1][2][3].
While the partnership has the potential to drive revenue growth, investors seek more detailed information on the financial implications and expected return on investment. Neogen currently operates with significant debt and wasn't profitable over the last twelve months. However, analysts predict the company will return to profitability this year [1]. Despite these positive results, Neogen's fiscal 2026 revenue guidance suggests flat to declining revenues when excluding its recently divested disinfectant business, contributing to a cautious stance from analysts [1].
References:
[1] https://in.investing.com/news/company-news/neogen-partners-with-biomatter-to-develop-enzymebased-food-safety-products-93CH-4956134
[2] https://www.nasdaq.com/articles/neogen-partners-biomatter-develop-advanced-enzyme-based-food-safety-solutions
[3] https://www.stocktitan.net/news/NEOG/neogen-establishes-relationship-with-xrg02sp6sf7c.html
NEOG--
Neogen Corp (NEOG) has partnered with Biomatter to develop innovative enzyme-based food safety solutions using Biomatter's AI-powered Intelligent Architecture platform and Neogen's analytical expertise. The collaboration aims to enhance detection, improve efficiency, and bolster the quality and safety of the global food supply. While the partnership has the potential to drive revenue growth, investors seek more detailed information on the financial implications and expected return on investment.
Neogen Corporation (NEOG) has entered into a strategic partnership with Biomatter to develop innovative enzyme-based food safety solutions. The collaboration leverages Biomatter's AI-powered Intelligent Architecture platform and Neogen's analytical expertise to enhance detection, improve efficiency, and bolster the quality and safety of the global food supply [1][2][3].Neogen, with a market capitalization of $1.1 billion and currently trading at $5.08, is a leading provider of food safety, livestock, and pet health solutions. The company operates in over 140 countries and generated annual revenue of $894.66 million in 2024. Biomatter, a next-generation enzyme design company, specializes in creating high-performance enzymes using its generative AI-powered Intelligent Architecture platform. The partnership aims to set new standards in the industry by making food and animal safety processes more efficient and cost-effective [1][2][3].
The collaboration combines Neogen's expertise in analytical development and technology with Biomatter's cutting-edge enzyme engineering capabilities. According to Dr. Jason Lilly, Neogen's Chief Scientific Officer, the partnership will unlock new possibilities that can enhance detection, improve efficiency, and ultimately protect and enhance the quality and safety of the global food supply [1][2][3].
Laurynas Karpus, Biomatter's Chief Executive Officer, stated that the collaboration aims to set new industry standards in food and animal safety. He emphasized that the partnership will make every step of the process more efficient, cost-effective, and ultimately more beneficial for the end user [1][2][3].
While the partnership has the potential to drive revenue growth, investors seek more detailed information on the financial implications and expected return on investment. Neogen currently operates with significant debt and wasn't profitable over the last twelve months. However, analysts predict the company will return to profitability this year [1]. Despite these positive results, Neogen's fiscal 2026 revenue guidance suggests flat to declining revenues when excluding its recently divested disinfectant business, contributing to a cautious stance from analysts [1].
References:
[1] https://in.investing.com/news/company-news/neogen-partners-with-biomatter-to-develop-enzymebased-food-safety-products-93CH-4956134
[2] https://www.nasdaq.com/articles/neogen-partners-biomatter-develop-advanced-enzyme-based-food-safety-solutions
[3] https://www.stocktitan.net/news/NEOG/neogen-establishes-relationship-with-xrg02sp6sf7c.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet